CorVel (CRVL) Form 144: 12,000-Share Sale via Morgan Stanley Disclosed
Rhea-AI Filing Summary
Form 144 notice for CorVel Corporation (CRVL): An insider has notified intent to sell 12,000 shares of Common stock through Morgan Stanley Smith Barney LLC on NASDAQ with an approximate aggregate market value of $1,069,975.20 based on the filing. The filing reports 51,312,748 shares outstanding for the issuer.
The filing shows the 12,000 shares were acquired on 08/20/2025 via stock option exercise and payment was made in cash on 08/20/2025. The filer also sold 2,400 shares on 06/09/2025 for gross proceeds of $259,416.00. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information.
Positive
- None.
Negative
- None.
Insights
TL;DR: Insider plans to sell 12,000 shares acquired by option exercise the same day; recent small sale also reported.
The Form 144 discloses a proposed sale executed through a broker on the Nasdaq. The shares to be sold were acquired by a stock option exercise and paid in cash on the stated acquisition date, which indicates a routine post-exercise disposition rather than a secondary issuance by the company. The filing documents a prior insider sale of 2,400 shares with reported gross proceeds, providing recent transactional context. For investors, this is a disclosure of insider liquidity activity; the filing does not present operational or financial company metrics.
TL;DR: Routine insider disclosure under Rule 144; includes required attestation about material nonpublic information.
The notice follows Rule 144 requirements by specifying broker, number of shares, acquisition method, payment type, and recent sales by the same person. It contains the customary signer representation that no undisclosed material adverse information exists. This filing is administrative and procedural in nature and does not, by itself, signal changes in corporate governance or strategy.